Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Tumours and immortalized cells avoid telomere attrition by using either the ribonucleoprotein enzyme telomerase or a recombination-based alternative lengthening of telomeres (ALT) mechanism. Available evidence from mice suggests that the epigenetic state of the telomere may influence the mechanism of telomere maintenance, but this has not been directly tested in human cancer. Here we investigated cytosine methylation directly adjacent to the telomere as a marker of the telomere's epigenetic state in a panel of human cell lines. We find that while ALT cells show highly heterogeneous patterns of subtelomeric methylation, subtelomeric regions in telomerase-positive cells invariably show denser methylation than normal cells, being almost completely methylated. When compared to matched normal and ALT cells, telomerase-positive cells also exhibit reduced levels of the telomeric repeat-containing-RNA (TERRA), whose transcription originates in the subtelomere. Our results are consistent with the notion that TERRA may inhibit telomerase: the heavy cytosine methylation we observe in telomerase-positive cells may reflect selection for TERRA silencing in order to facilitate telomerase activity at the telomere. These data suggest that the epigenetic differences between telomerase-positive and ALT cells may underlie the mechanism of telomere maintenance in human tumorigenesis and highlight the broad reaching consequences of epigenetic dysregulation in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 2×
“In around 85% of tumours, telomere length maintenance is achieved by activation of telomerase (6); telomerase activity is not detectable or present at very low levels in most normal human somatic cells (3).”
BackgroundMethodThe limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
A survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794 · cited 1×
“In around 85% of tumours, telomere length maintenance is achieved by activation of telomerase (6); telomerase activity is not detectable or present at very low levels in most normal human somatic cells (3).”
BackgroundBryan, T. M., Englezou, A., Dalla-Pozza, L., Dunham, M. A., & Reddel, R. R. (1997) · Nature Medicine · doi:10.1038/nm1197-1271 · Cited by 1,292 · cited 1×
“About 10–15% of tumours exhibit telomere stabilization in the absence of telomerase activity, via the alternative lengthening of telomeres (ALT) mechanism (7).”
BackgroundSelf-citationGrewal, S. I. S., & Jia, S. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2008 · Cited by 1,263 · cited 2×
“Thus, telomeric regions can be considered as epigenetic structures that are maintained as constitutive heterochromatin (11).”
BackgroundTelomere maintenance by recombination in human cells
Dunham, M. A., Neumann, A. A., Fasching, C. L., & Reddel, R. R. (2000) · Nature Genetics · doi:10.1038/82586 · Cited by 879 · cited 1×
“SV40-transformed cells were derived by transfecting fibroblasts from a single individual with SV40 early region gene constructs, isolating individual foci of morphologically transformed cells, and culturing them continuously; cells that became immortalized were categorized as telomerase-positive based on a telomerase…”
MethodSelf-citationStructure and variability of human chromosome ends.
de Lange, T., Shiue, L., Myers, R. M., Cox, D. R., Naylor, S. L., Killery, A. M., & Varmus, H. E. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.2.518 · Cited by 848
The rate of telomere sequence loss in human leukocytes varies with age
Frenck, R. W., Blackburn, E. H., & Shannon, K. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5607 · Cited by 675 · cited 1×
“This finding suggests that the heterochromatic state of human telomeres is maintained despite the known telomere attrition that occurs with age, especially in the first few years of life (21).”
Background
Cited by
The hallmarks of cancer: A long non-coding RNA point of view
Gutschner, T., & Diederichs, S. (2012) · RNA Biology · doi:10.4161/rna.20481 · Cited by 1,802
Alternative lengthening of telomeres: models, mechanisms and implications
Cesare, A. J., & Reddel, R. R. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2763 · Cited by 1,035
Self-citationLong non-coding RNAs and cancer: a new frontier of translational research?
Spizzo, R., Almeida, M. I., Colombatti, A., & Calin, G. A. (2012) · Oncogene · doi:10.1038/onc.2011.621 · Cited by 1,004
Long noncoding RNAs and the genetics of cancer
Cheetham, S. W., Gruhl, F., Mattick, J. S., & Dinger, M. E. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.233 · Cited by 724
Lovejoy, C. A., Li, W., Reisenweber, S., Thongthip, S., Bruno, J., de Lange, T., De, S., Petrini, J. H. J., Sung, P. A., Jasin, M., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002772 · Cited by 629
“In addition to shelterin and TERRA, we analyzed 299 genes with potential relevance to telomeres and the ALT pathway.”
BackgroundInfluentialSelf-citationThe bright side of dark matter: lncRNAs in cancer
Evans, J. R., Feng, F. Y., & Chinnaiyan, A. M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84421 · Cited by 451
Telomeric RNA-DNA hybrids affect telomere-length dynamics and senescence
Balk, B., Maicher, A., Dees, M., Klermund, J., Luke-Glaser, S., Bender, K., & Luke, B. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2662 · Cited by 296
TERRA: telomeric repeat‐containing RNA
Luke, B., & Lingner, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.166 · Cited by 266
Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets
Fatima, R., Akhade, V. S., Pal, D., & Rao, S. M. (2015) · Molecular and Cellular Therapies · doi:10.1186/s40591-015-0042-6 · Cited by 263
Novel roles for A-type lamins in telomere biology and the DNA damage response pathway
Gonzalez‐Suarez, I., Redwood, A. B., Perkins, S. M., Vermolen, B., Lichtensztejin, D., Grotsky, D. A., Morgado‐Palacin, L., Gapud, E. J., Sleckman, B. P., Sullivan, T., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.196 · Cited by 246
Cusanelli, E., & Chartrand, P. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00143 · Cited by 209
“TERRA expression is induced in ALT cells (Ng et al., 2009; Arora et al., 2014) and recent evidence indicate that while TERRA levels decrease from S phase to G2 phase in telomerase-positive cancer cells (Porro et al., 2010), TERRA foci significantly increase during S phase and G2 in ALT cells (Flynn…”
BackgroundThe Emerging Roles of TERRA in Telomere Maintenance and Genome Stability
Bettin, N., Oss Pegorar, C., & Cusanelli, E. (2019) · Cells · doi:10.3390/cells8030246 · Cited by 169
“In mammalian cells, elevated levels of telomeric R-loops are detected in telomerase-negative ALT cancer cells [114], which express higher levels of TERRA as compared to telomerase-positive cancer cells [54,80].”
BackgroundRole of TERRA in the regulation of telomere length
Wang, C., Zhao, L., & Lu, S. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.10528 · Cited by 89
Zhang, X., Li, B., de Jonge, N., Björkholm, M., & Xu, D. (2015) · Oncotarget · doi:10.18632/oncotarget.2917 · Cited by 38
“[53] The obtained PCR products were then sequenced at both directions.”
Background
Metadata
- Authors
- Ng, L. J., Cropley, J. E., Pickett, H. A., Reddel, R. R., & Suter, C. M.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-01-07
- Volume
- 37
- Issue
- 4
- Pages
- 1152-1159
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2137153793
- Cited by
- 158
- References
- 9
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.